Maine 2025-2026 Regular Session

Maine House Bill LD604

Introduced
2/20/25  
Refer
2/20/25  
Engrossed
5/22/25  
Enrolled
5/22/25  

Caption

An Act to Ensure Access to Concurrent Methadone Treatment and Intensive Outpatient Programs

Impact

If enacted, LD604 would have a significant impact on the healthcare landscape for individuals dealing with opioid dependence in Maine. By strengthening access to methadone treatment alongside intensive outpatient programs, the bill is likely to enhance the continuity and effectiveness of care for those struggling with substance use disorders. This legislative measure reflects an attempt to break down existing barriers that hinder comprehensive treatment options, which are essential for effective recovery and support for individuals affected by addiction.

Summary

Legislative Document 604, titled 'An Act to Ensure Access to Concurrent Methadone Treatment and Intensive Outpatient Programs', is designed to ensure that individuals enrolled in the MaineCare program have unfettered access to methadone maintenance as a treatment for opioid use disorder. The bill prohibits the Department of Health and Human Services from imposing any coverage restrictions related to methadone treatment while also allowing participants to engage concurrently in medically appropriate intensive outpatient programs and other related outpatient services. This aims to foster a more integrated approach to treatment for substance use and behavioral health disorders.

Sentiment

The sentiment surrounding LD604 appears supportive among various stakeholders, particularly those invested in addiction recovery and mental health advocacy. Proponents of the bill argue it represents a progressive step towards increasing accessibility to essential treatment services for individuals facing opioid use disorders. However, there may be concerns from some quarters regarding the costs associated with expanded coverage and potential overuse of services, although specific opposition details were not highlighted in the current discussions.

Contention

While the bill is largely viewed favorably, there are nuanced discussions about the potential implications for state resources and the operational capabilities of treatment providers to implement the new requirements. Some stakeholders may raise issues regarding the management of concurrent treatment plans and the necessary training for healthcare professionals involved in administering dual services. This highlights ongoing conversations about balancing treatment access with the sustainable provision of healthcare resources.

Companion Bills

No companion bills found.

Previously Filed As

ME HB2349

To offer long-acting reversible contraception to patients receiving methadone and suboxone at the treatment facility for the methadone and suboxone

ME HB4196

To offer long-acting reversible contraception to patients receiving methadone and suboxone at the treatment facility for the methadone and suboxone

ME SB542

Relating to violations and penalty for standalone methadone treatment programs or clinics

ME HB2387

MHDD CD-OUTPATIENT TREATMENT

ME S810

Authorizes outpatient substance use disorder treatment programs to make housing available under certain circumstances.

ME AB1676

Mental health services: assisted outpatient treatment: involuntary medication.

ME S777

Increases Medicaid reimbursement for in-person partial care and intensive outpatient behavioral health and substance use disorder treatment services, and associated transportation services, for adults.

ME A1796

Increases Medicaid reimbursement for in-person partial care and intensive outpatient behavioral health and substance use disorder treatment services, and associated transportation services, for adults.

ME S3118

Establishes "Remote Methadone Dosing Pilot Program;" appropriates $225,000.

ME A2378

Establishes "Remote Methadone Dosing Pilot Program;" appropriates $225,000.

Similar Bills

No similar bills found.